 PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 21, 2021 GLOBE NEWSWIRE -- Adaptimmune Therapeutics plc Nasdaq:ADAP, a leader in cell therapy to treat cancer, will report financial results and provide a business update for the third quarter ended September 30, 2021, before the US markets open on Thursday, November 4, 2021. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EDT 12:00 p.m. GMT that same day details below. 